Evidence map›Paper›PMID 22162907›Full record

ArticleAmerican journal of respiratory cell and molecular biology2012

Albuterol modulates its own transepithelial flux via changes in paracellular permeability.

Hoshang J Unwalla, Gabor Horvath, Felix D Roth, Gregory E Conner, Matthias Salathe

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.Handbook of experimental pharmacology · 2024
    Review
  7. Article
  8. Review
  9. The leaky lung test: a pilot study using inhaled mannitol to measure airway barrier function in asthma.The Journal of asthma : official journal of the Association for the Care of Asthma · 2019
    Article
  10. Article
  11. A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hoshang J UnwallaDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Miami and Miller School of Medicine, Florida, USA.
Gabor Horvath
Felix D Roth
Gregory E Conner
Matthias Salathe
University of Miami · USSemmelweis University · HUSleepMed · US

Funding

PHOSPHORYLATION OF CILIARY TARGET PROTEINSR01HL060644 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SALATHE, MATTHIAS A · 1999 to 2011
$3.4M
REGULATION OF AIRWAY LACTOPEROXIDASE HOST DEFENSER01HL066125 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CONNER, GREGORY E. · 2001 to 2009
$2.4M
Mucociliary Function in Chronic BronchitisR01HL089399 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SALATHE, MATTHIAS A · 2007 to 2010
$1.5M
NHLBI NIH HHS HL-060644NHLBI NIH HHS HL-066125NHLBI NIH HHS HL-089399NHLBI NIH HHS R01 HL060644NHLBI NIH HHS R01 HL066125NHLBI NIH HHS R01 HL089399
6 · The paper itself

Abstract

Although inhaled bronchodilators are commonly used in the treatment of airway disease to dilate airway smooth muscle, little is known regarding the mechanisms that regulate albuterol movement across the epithelium to reach its target, the airway smooth muscle. Because the rate of onset depends on the transepithelial transport of albuterol, to determine the mechanisms that regulate the transepithelial movement of albuterol is essential. Human bronchial epithelial cells, fully redifferentiated in culture at the air-liquid interface, were used to study the cellular uptake and total transepithelial flux of (3)H-albuterol from the apical to the basolateral surfaces. (3)H-mannitol and transepithelial electrical resistance were used to quantify changes in paracellular permeability. The majority of albuterol flux across the epithelium occurred via the paracellular route. The cellular uptake of albuterol was found to be saturable, whereas transepithelial flux was not. Cellular uptake could be inhibited by the amino acids lysine and histidine, with no effect on net transepithelial flux. Transepithelial flux was altered by maneuvers that collapsed or disrupted intercellular junctions. Acidification, usually seen in exacerbations of airway disease, decreased albuterol flux. In addition, albuterol increased its own paracellular permeability. The ability of albuterol to modulate paracellular permeability was blocked by the β(2)-adrenergic receptor-selective antagonist ICI 118551. Albuterol mainly crosses the epithelium via the paracellular pathway, but has the ability to modulate its own permeability through changes in the leakiness of tight junctions, which is modulated through the signaling of the β(2)-adrenergic receptor.

Indexed as

Adrenergic beta-2 Receptor AgonistsAdrenergic beta-AntagonistsAlbuterolBronchiBronchodilator AgentsCell Membrane PermeabilityCells, CulturedElectric ImpedanceEpithelial CellsHumansIntercellular JunctionsPropanolaminesTight JunctionsAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AntagonistsAlbuterolBronchodilator AgentsICI 118551Propanolamines

Identifiers

PMID22162907
PMCPMC3359945
OpenAlexW2123133301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.